London Global Cancer Week 2022

THE EFFECTS OF THE COVID PANDEMIC ON CANCER TREATMENT

Opportunities For Collaboration And Innovation

03:30 PM TO 05:30 PM (Pakistan Standard Time), Friday, 18th November, 2022

The American Association of Continuing Medical Education accredits this educational activity
for a maximum of 2.25 category I AACME credit hours.

Feedback & To Claim CME Credits

Session Chairs

– Prof Richard Sullivan, Director, Institute of Cancer Policy and Co-Director of the Centre for Conflict & Health Research, King’s College, London, UK

– Aasim Yusuf, Chief Medical Officer, Shaukat Khanum Memorial Cancer Hospital & Research Centres, Lahore & Peshawar, Pakistan

 

An Introduction To The Cancer And Covid-19 Taskforce

Prof Richard Sullivan, Director, Institute of Cancer Policy and Co-Director of the Centre for Conflict & Health Research, King’s College, London, UK

 

The Effects Of The Covid Pandemic On Cancer Treatment

Speakers & Presentations

Dorothy Lombe

Consultant Radiation Oncologist
Cancer Screening, Treatment and Support, MidCentral, New Zealand

’Silver Linings of the COVID-19 Pandemic: Accelerated Steps to Technology Sharing – Vaccines Made in Africa’

–        Impact of the COVID-19 pandemic in Africa

–        Inequities in access to the vaccine against SARS CoV-2

Revolution in African leaders to shift the status quo

Fawad ul Qamar
Head of Clinical and Radiation Oncology, Shaukat Khanum Memorial Cancer Hospital & Research Centre, Peshawar, Pakistan

“Innovations in Cancer Care During and Beyond COVID-19 Pandemic”

–        Innovations and strategies adopted during COVID 19

–        Experiences during the pandemic impacting quality of care

–        Use of hypo-fractionated radiotherapy regimens for breast cancer, tele-medicine and virtual MDT services.

–        Continuing these strategies to meet the growing demand for cancer care services

Deborah Mukherji
Medical Oncologist
Clemenceau Medical Center, Dubai,
United Arab Emirates

“Re-defining Global Cancer Research-Priorities after COVID-19″

–        How COVID-19 and Cancer Global Taskforce has been engaging with international stakeholders

–        Focus on Low and Middle-Income Countries

–        Re-defining cancer research priorities following the COVID-19 pandemic

Raúl Murillo

Director, Centro Javeriano de Oncología, Hospital Universitario San Ignacio, Assistant Professor, Faculty of Medicine, Pontificia Universidad Jveriana, Bogotá, Colombia

–        The context of the Colombian health system

–        The pandemic waves and the lockdown

–        Trends of demand of oncology services at a reference centre

–        Clinical stage at diagnosis

 

For more details, please write to us at communications@skm.org.pk.